November 2023

Cyted appoints Gail Marcus as Chair of the Board

Back to news

Cambridge, UK: Cyted, a company working on non-endoscopic diagnostics for digestive diseases, today announces that Gail Marcus has been named as the company’s Board Chair and Non-Executive Director, to support the business’s entry into the US market. She will be taking over from Will West who has served for over 3 years as Board Chair and will retain an active role on the Board.

“This milestone appointment brings an invaluable addition to the Cyted team. Gail will help drive forward work taking our minimally-invasive EndoSign® test for the pre-cancerous condition Barrett’s esophagus to patients across the US,” said Marcel Gehrung, Cyted CEO and Co-founder. “With an exceptional record of leadership in pioneering diagnostic technology companies and a deep understanding of US healthcare, she is unrivalled in terms of expertise for this post. I would also like to thank Will West for his outstanding contribution in the role and developing the organization in recent years.”

“I am excited to be leading Cyted’s expansion in the US alongside the team and determined to make sure many more physicians have the opportunity to provide convenient, accessible diagnostics to their patients,” said Marcus. “The potential to transform the way we monitor patients with chronic reflux and identify those at risk of developing cancer using minimally-invasive diagnostics is huge.”

Gail currently serves on the board of Natera (NTRA), a leading women’s health and molecular diagnostics company. She also serves on private company boards, including PathAI and Biomodal (formerly Cambridge Epigenetix). Gail is an Assistant Professor at Hofstra University in the Master’s in Health Administration program.

Prior to her current roles, Gail held senior leadership positions at CIGNA and United Healthcare and served as CEO of Caris Diagnostics, a pioneer in cancer care, and Calloway Labs, a biotechnology firm specialising in clinical toxicology laboratory services. Gail has received a DHA from the Medical University of South Carolina, an MBA in Finance from The Wharton School, an MSE in Information Sciences from the University of Pennsylvania, and a BA in Mathematics and Spanish from Wesleyan University.

No items found.